VANGUARD GROUP INC - THE ONCOLOGY INSTITUTE INC ownership

THE ONCOLOGY INSTITUTE INC's ticker is and the CUSIP is 68236X100. A total of 30 filers reported holding THE ONCOLOGY INSTITUTE INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of THE ONCOLOGY INSTITUTE INC
ValueSharesWeighting
Q3 2023$2,461,248
+153.7%
1,758,034
-0.3%
0.00%
Q2 2023$969,975
-26.4%
1,762,950
-9.3%
0.00%
Q1 2023$1,317,528
-58.7%
1,943,543
+0.6%
0.00%
Q4 2022$3,188,799
-63.0%
1,932,606
+3.9%
0.00%
Q3 2022$8,613,000
+8.0%
1,860,242
+18.1%
0.00%
Q2 2022$7,972,000
+33.4%
1,575,435
+87.9%
0.00%
Q1 2022$5,977,000
+38.6%
838,321
+89.5%
0.00%
Q4 2021$4,313,000442,3440.00%
Other shareholders
THE ONCOLOGY INSTITUTE INC shareholders Q1 2022
NameSharesValueWeighting ↓
Velan Capital Investment Management LP 600,000$5,850,0004.54%
Empery Asset Management, LP 200,000$1,950,0004.07%
Parian Global Management LP 466,676$4,550,0003.65%
Triatomic Management LP 400,000$3,900,0002.39%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,296,107$32,137,0000.67%
Redmile Group, LLC 2,500,000$24,375,0000.55%
Alpine Global Management, LLC 384,988$3,754,0000.55%
CVI Holdings, LLC 200,000$1,950,0000.13%
Saba Capital Management, L.P. 400,000$3,732,0000.06%
FMR LLC 12,000,000$111,150,0000.01%
View complete list of THE ONCOLOGY INSTITUTE INC shareholders